Caxton Corporation’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.7K | Sell |
17,332
-519
| -3% | -$2.09K | 0.71% | 9 |
|
|
2025
Q1 | $61.9K | Hold |
17,851
| – | – | 1.22% | 7 |
|
|
2024
Q4 | $117K | Hold |
17,851
| – | – | 0.71% | 8 |
|
|
2024
Q3 | $161K | Hold |
17,851
| – | – | 0.67% | 7 |
|
|
2024
Q2 | $286K | Buy |
17,851
+7,532
| +73% | +$121K | 1.45% | 5 |
|
|
2024
Q1 | $162K | Hold |
10,319
| – | – | 0.92% | 9 |
|
|
2023
Q4 | $138K | Buy |
+10,319
| New | +$138K | 0.75% | 9 |
|